SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-21-009300
Filing Date
2021-04-20
Accepted
2021-04-20 21:42:31
Documents
1
Period of Report
2021-04-16

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1523
  Complete submission text file 0001493152-21-009300.txt   3129
Mailing Address 1185 AVENUE OF THE AMERICAS 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS 3RD FLOOR NEW YORK NY 10036 856-848-8698
MyMD Pharmaceuticals, Inc. (Issuer) CIK: 0001321834 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O AKERS BIOSCIENCES, INC. 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address
Rivard Paul (Reporting) CIK: 0001857479 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36268 | Film No.: 21839320